|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0013216,
umls-concept:C0075804,
umls-concept:C0087111,
umls-concept:C0183683,
umls-concept:C0282461,
umls-concept:C0344211,
umls-concept:C0439858,
umls-concept:C1171411,
umls-concept:C1274040,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1511572,
umls-concept:C1521721,
umls-concept:C1522673,
umls-concept:C1637379,
umls-concept:C1707455
|
|
pubmed:issue |
9501
|
|
pubmed:dateCreated |
2005-12-5
|
|
pubmed:abstractText |
Breast cancer with extensive axillary-lymph-node involvement has a poor prognosis after conventional treatment. In trials with historical controls, high-dose chemotherapy produced improved outcomes. We compared an intensive double-cycle high-dose chemotherapy regimen with an accelerated conventionally dosed regimen in high-risk breast cancer in a multicentre trial.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:BaltzerJörgJ,
pubmed-author:BenderHans GeorgHG,
pubmed-author:BerdelWolfgang EWE,
pubmed-author:FischerJohannesJ,
pubmed-author:FrickMarkusM,
pubmed-author:HinkeAxelA,
pubmed-author:JackischChristianC,
pubmed-author:KirchnerHartmutH,
pubmed-author:LindemannWalterW,
pubmed-author:MetznerBerndB,
pubmed-author:MiddeckeConstantinC,
pubmed-author:MohrmannSvjetlanaS,
pubmed-author:NitzUlrike AnnelieseUA,
pubmed-author:PollmannsAnkeA,
pubmed-author:RöselSiegfriedS,
pubmed-author:RøeCC,
pubmed-author:RuffertUteU,
pubmed-author:SchüttGerhartG,
pubmed-author:SchmollHans JoachimHJ,
pubmed-author:SchraderIrisI,
pubmed-author:SchwenzerThomasT,
pubmed-author:SouchonRainerR,
pubmed-author:WernerChristophC,
pubmed-author:WernetPeterP,
pubmed-author:West German Study Group,
pubmed-author:WiebringhausHerrmannH,
pubmed-author:ZiskeCarstenC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
366
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1935-44
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16325695-Adult,
pubmed-meshheading:16325695-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16325695-Breast Neoplasms,
pubmed-meshheading:16325695-Chemotherapy, Adjuvant,
pubmed-meshheading:16325695-Combined Modality Therapy,
pubmed-meshheading:16325695-Cross-Over Studies,
pubmed-meshheading:16325695-Disease-Free Survival,
pubmed-meshheading:16325695-Dose-Response Relationship, Drug,
pubmed-meshheading:16325695-Drug Administration Schedule,
pubmed-meshheading:16325695-Female,
pubmed-meshheading:16325695-Humans,
pubmed-meshheading:16325695-Middle Aged,
pubmed-meshheading:16325695-Peripheral Blood Stem Cell Transplantation
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial.
|
|
pubmed:affiliation |
Breast Centre, University Hospital Düsseldorf, Düsseldorf, Germany. nitzu@uni-duesseldorf.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
